Clinical Trial Update: Xeloda (Capecitabine) and External Beam Radiation [Phase 2]

View source ↗

Summary

A Phase 2 trial of capecitabine (Xeloda) in combination with external beam radiation for breast cancer has completed enrollment, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-06-28